Our results from statistical models, feature selection, and machine learning classifiers supported that IgM anti-HPT78−108 HNE, IgM anti-IGKC2−19, and IgM anti-IGKC2−19 HNE showed potential to be developed as biomarkers for RA. The gene discussed is CD40LG; the disease is rheumatoid arthritis.